Mackenzie Financial
ATRS

Mackenzie Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Mackenzie Financial’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,015
Closed -$45K – 1581
2022
Q1 		$45K Buy
+11,015
New +$40K ﹤0.01% 1372

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mackenzie Financial's ATRS Position: Q2 2022 in Review

Mackenzie Financial sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 11,015 shares — an estimated $45K sold.

Mackenzie Financial first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $45K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Mackenzie Financial reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Mackenzie Financial sold 11,015 Antares Pharma, Inc. shares in Q2 2022, an estimated $45K.
  • Mackenzie Financial first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Mackenzie Financial's Antares Pharma, Inc. position peaked at $45K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Mackenzie Financial's 13F filing for Q2 2022, filed 10 Aug 2022.